This analysis covers current and future diagnostic techniques in neurological conditions and looks at the impact of developments over the next 10 years on key stakeholders (diagnostic companies, pharmaceutical companies, payers and patients).

The TriMark Molecular Diagnostics Conference 2008 has been organized to provide a critical examination of the molecular diagnostics industry, as well as to provide insight from key industry leaders concerning cutting-edge molecular diagnostics technolo

Bionanotechnology will have a great impact on life science industries such as medical device, biotech equipment, diagnostic, and pharmaceuticals.

An insight into the market and an overview of the latest trends and collaborations between the different industry sectors